6
Jul 2026
New viral insights lay foundation for treating infection with JC polyomaviruses
In people with severely compromised immune systems, the JC polyomavirus can trigger a currently untreatable, usually fatal brain disease.
Stay Informed!
6
Jul 2026
New HIV vaccine successfully generates broadly neutralizing antibodies in primates
A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists, and IAVI has the potential to protect humans from developing HIV infection and AIDS.
6
Jul 2026
Study identifies promising drug target to prevent neurodegenerative conditions
Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.
6
Jul 2026
New spatially resolved transcriptomic map reveals how bone and muscle cells communicate
A new study generated one of the most comprehensive spatially resolved transcriptomic maps of cellular communication between bone and skeletal muscle in a young mouse.
6
Jul 2026
New conceptual model links sacred moments to clinician well-being
In health care, it is often the smallest moments that carry the greatest meaning - a quiet conversation with a patient, a shared reflection with colleagues, or a hand held in silence.
6
Jul 2026
Case study shows how accurate diagnosis can guide personalized treatment for renal oncocytoma
A new case report was published in Volume 17 of Oncotarget on July 2, 2026, titled "Renal oncocytoma: Α case report and literature review."
6
Jul 2026
Study compares different light therapies for treating Alzheimer's disease
The researchers treated 5‑month‑old 5xFAD mice – a model with aggressive amyloid deposition – with 810‑nm light (25 mW/cm² at the scalp, ~6.25 mW/cm² brain dose for CW, and half that for 40‑Hz due to 50% duty cycle) for 10 minutes daily over 37 days.
6
Jul 2026
Korea University College of Medicine selected as the lead institution for hantavirus vaccine development project
The Vaccine Innovation Center at Korea University College of Medicine has been selected by the Korea Disease Control and Prevention Agency (KDCA) as the lead institution for a national hantavirus vaccine development project.
6
Jul 2026
Study finds specialized gambling addiction services underused in Quebec
A new study finds public specialized gambling addiction treatment services are underused in Quebec, pointing to a need to better reach people with gambling disorder.
6
Jul 2026
Study explores the relationship between heart issues and cognitive function
New in JNeurosci, Xia Zhang, from the Max Planck Institute for Human Cognitive and Brain Sciences, led a study exploring the relationship between heart issues and cognitive function.
